WHO ICTRP trial

study of Dhatryadi Kwatha and Shatavaryadi Kwatha in cystitis

CTRI/2021/11/038259 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2021/11/038259
Public title study of Dhatryadi Kwatha and Shatavaryadi Kwatha in cystitis
Scientific title An open labelled, randomised, comparative clinical study to evaluate the efficacy of Dhatryadi Kwatha and Shatavaryadi Kwatha in Pittaj Mootrakrichchhra.
Primary sponsor Dr Arjun Sable
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2
Countries India
Conditions Health Condition 1: N300- Acute cystitis
Interventions Intervention1: Dhatryadi Kwatha: 20 ml twice a day with anupan jala route- per oral duration- 5days Control Intervention1: Shatavaryadi Kwatha: 20 ml twice a day with anupan jala route- per oral duration- 5 days
Registration date Nov 25, 2021
Target size 60
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations